STAT3 phosphorylation activation at Tyr705 is shown to provide a growth advantage by upregulating the expression of c-Myc through binding to its promoter in NKTCL [19, 20]. The gene discussed is MYC; the disease is extranodal nasal NK/T cell lymphoma.